Has ResMed (RMD) Outpaced Other Medical Stocks This Year?

Investors focused on the Medical space have likely heard of ResMed (RMD), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of RMD and the rest of the Medical group's stocks.

ResMed is a member of our Medical group, which includes 903 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. RMD is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for RMD's full-year earnings has moved 0.15% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the latest available data, RMD has gained about 32.69% so far this year. Meanwhile, stocks in the Medical group have gained about 1.97% on average. This means that ResMed is outperforming the sector as a whole this year.

Looking more specifically, RMD belongs to the Medical - Products industry, a group that includes 81 individual stocks and currently sits at #159 in the Zacks Industry Rank. Stocks in this group have lost about 1.96% so far this year, so RMD is performing better this group in terms of year-to-date returns.

Investors in the Medical sector will want to keep a close eye on RMD as it attempts to continue its solid performance.

Click to get this free report

ResMed Inc. (RMD): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More